Tri Locum Partners’s Curis CRIS Stock Holding History

Tri Locum Partners’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-902	Closed	-$2.95M	–	51
2020 Q4	$2.95M	Buy	+902	New	+$1.08M	1.07%	26

Other funds holding CRIS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Tri Locum Partners's CRIS Position: Q1 2021 in Review

Tri Locum Partners sold out of Curis (CRIS) in Q1 2021, closing a stake of 902 shares — an estimated $2.95M sold.

Tri Locum Partners first reported a position in CRIS in Q4 2020 and held it in 1 quarter. The position peaked at $2.95M in Q4 2020. 122 funds tracked by Wall St. Rank hold CRIS as of Q1 2021.

Tri Locum Partners reported no remaining Curis position as of Q1 2021 after selling out during the quarter.
Tri Locum Partners sold 902 Curis shares in Q1 2021, an estimated $2.95M.
Tri Locum Partners first reported a position in Curis in Q4 2020 and held it in 1 quarter.
Tri Locum Partners's Curis position peaked at $2.95M in Q4 2020.
122 funds tracked by Wall St. Rank held Curis as of Q1 2021.

Based on Tri Locum Partners's 13F filing for Q1 2021, filed 17 May 2021.